119 related articles for article (PubMed ID: 37883634)
21. Decreased serum bone specific alkaline phosphatase and increased urinary N-terminal telopeptide of type I collagen as prognostic markers for bone mineral density loss in HIV patients on cART.
Koga I; Seo K; Yoshino Y; Kitazawa T; Kurahashi I; Ota Y
J Infect Chemother; 2016 Aug; 22(8):543-7. PubMed ID: 27346381
[TBL] [Abstract][Full Text] [Related]
22. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
23. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study.
König D; Oesser S; Scharla S; Zdzieblik D; Gollhofer A
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29337906
[No Abstract] [Full Text] [Related]
24. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism.
Shetty S; Cherian KE; Shetty S; Kapoor N; Jebasingh FK; Cherian A; Hephzibah J; Chandramohan A; John RA; Asha HS; Paul MJ; Manipadam MT; Abraham DT; Thomas N; Paul TV
Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
26. Determinants of bone density in healthy older men with low testosterone levels.
Kenny AM; Prestwood KM; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
[TBL] [Abstract][Full Text] [Related]
27. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
28. Bone turnover in elderly men: relationships to change in bone mineral density.
Nguyen TV; Meier C; Center JR; Eisman JA; Seibel MJ
BMC Musculoskelet Disord; 2007 Feb; 8():13. PubMed ID: 17316428
[TBL] [Abstract][Full Text] [Related]
29. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
30. Diverging results of areal and volumetric bone mineral density in Down syndrome.
García-Hoyos M; García-Unzueta MT; de Luis D; Valero C; Riancho JA
Osteoporos Int; 2017 Mar; 28(3):965-972. PubMed ID: 27838733
[TBL] [Abstract][Full Text] [Related]
31. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
32. Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women.
Wei QS; Huang L; Tan X; Chen ZQ; Chen SM; Deng WM
Scand J Clin Lab Invest; 2016; 76(1):33-9. PubMed ID: 26414945
[TBL] [Abstract][Full Text] [Related]
33. Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial.
Fuchs RK; Bauer JJ; Snow CM
J Bone Miner Res; 2001 Jan; 16(1):148-56. PubMed ID: 11149479
[TBL] [Abstract][Full Text] [Related]
34. Relation of Age, Sex and Bone Mineral Density to Serum 25-Hydroxyvitamin D Levels in Chinese Women and Men.
Wei QS; Chen ZQ; Tan X; Su HR; Chen XX; He W; Deng WM
Orthop Surg; 2015 Nov; 7(4):343-9. PubMed ID: 26791959
[TBL] [Abstract][Full Text] [Related]
35. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
[TBL] [Abstract][Full Text] [Related]
36. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
39. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
[TBL] [Abstract][Full Text] [Related]
40. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
